Article

Imagine Eyes presents line of adaptive optics products

Imagine Eyes' adaptive optics products aim to improve the success rate of refractive surgery procedures by simulating the influence on vision of higher-order aberrations, according to the company.

Imagine Eyes' adaptive optics products aim to improve the success rate of refractive surgery procedures by simulating the influence on vision of higher-order aberrations, according to the company.

The crx1 Adaptive Optics Visual Simulator enables clinicians to measure, correct, and manipulate the optical aberrations of eyes with extreme precision. The device combines quality Shack-Hartmann wavefront technology with a mirao 52-d Electromagnetic Deformable Mirror. The simulator's internal fixation target is made of a miniature monitor that allows clinicians to stimulate patients' vision using almost any visual test. Key functionalities include ocular wavefront measurement, adaptive-optics custom-wavefront correction, user-defined adaptive optics wavefront generation, visual performance assessment through user-defined wavefront aberrations, and wavefront assessment of accommodation.

The irx3 Wavefront Aberrometer combines precision and range with an easy-to-use software interface into one turnkey solution. The aberrometer's repeatability combined with analytical tools, including objective wavefront accommodation assessment, makes it ideal for demanding researchers and clinicians alike.

For more information, visit Imagine Eyes at Booth 918.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.